Atlas Trials

Study of TV-1106 in Growth Hormone-Deficient Adults

Clinical trial NCT02410343 · TERMINATED

Trial details

NCT number
NCT02410343
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Growth Hormone Deficiency
Start date
2015-04-30
Primary completion
2015-12-31
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.